Revelation Biosciences's total assets for Q1 2025 were $3.97M, a decrease of -40.04% from the previous quarter. REVB total liabilities were $1.09M for the fiscal quarter, a -43.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.